Revvity, Inc. (RVTY) stock analysis
RVTY · Revvity, Inc.
Latest recorded price: USD 148.85
Model-estimated fair value: USD 28.06. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Diagnostics & Research
At $148.85, RVTY trades 430.4% above the model's base-case value of $28.06. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $18.26 in the conservative case and $39.07 in the optimistic case, with a valuation confidence score of 45/100. Fiscal 2025 figures: revenue growth -4.8%, free cash flow margin 17.8%, ROIC 3.0%. The model flags 1 risk signal for this company.